| Name | Title | Contact Details |
|---|
Chesme Capital Management is a Dewitt, MI-based company in the Financial Services sector.
Chapman Investments Ext is a Montgomery, AL-based company in the Financial Services sector.
Markit is a leading global diversified provider of financial information services. We provide products that enhance transparency, reduce risk and improve operational efficiency. Our customers include banks, hedge funds, asset managers, central banks, regulators, auditors, fund administrators and insurance companies. Founded in 2003, we employ over 3,500 people in 10 countries. Markit shares are listed on Nasdaq under the symbol MRKT.
Goldspot Discoveries Inc. is a technology/investment company that uses artificial intelligence and machine learning to significantly improve mineral exploration targeting on both a regional and local scale. We have proven that data science mitigates investment risk and increases the efficiency and success rate of exploration in data-rich environments. The company plans to lever this technology to create a new and exciting investment opportunity for the market, and to give its stakeholders the greatest upside in the mining sector while reducing the risk. Managed by seasoned industry experts from both financial and technical backgrounds; the team is armed with an unique technological edge. Achievements to date include 2nd place at the Integra Gold Challenge and finalists at Goldcorp`s #Disruptmining. Goldspot Discoveries is aiming to completely change the investment decision model by using data science to stake acreage, acquire projects and royalties, and invest in public vehicles to ultimately create a portfolio of assets with the greatest reward to risk ratio. We are expanding! If you have a background in machine learning, geology, or finance, and want to be a part of this exciting start-up, drop us a line!
BullFrog AI is an investor-backed company determined to become the undisputed leader in precision medicine. Our mission is to find the link between therapies and patients, and improve their lives. Using our proprietary technology platform, we aim to predict which patients will benefit from which medications, effectively improving clinical outcomes and eliminating the problem of trial-and-error prescriptions. We have an exceptional team of life science industry leaders, AI technologists, scientists, physicians and advisors determined to help BullFrog AI revolutionize drug development. Through our partnership with one of the most prestigious research institutions in the world, we take pride in technology innovation by staying on the cutting edge of AI.